Optic neuropathy related to Onodi cell mucocele: a systematic review and meta-analysis of randomized controlled trials

Author:

Mahfoz Turki M. Bin, ,Alnemare Ahmad K.,

Abstract

<abstract><sec> <title>Background</title> <p>Onodi cells (OC) are important for rhinologists because they contain the optic canal, and are close to the optic nerve and internal carotid artery. Therefore, any pathologic processes within OCs, including infectious or inflammatory sinusitis, fungus ball, inverted papilloma, mucocele, or sino-nasal malignancy can cause devastating ophthalmologic complications. We aimed to define the different optic neuropathy conditions related to isolated OC mucoceles, determine the different symptoms of each condition and its risk factors, and explore the efficacy of the relevant diagnostic tools and treatment strategies.</p> </sec><sec> <title>Methodology</title> <p>A comprehensive electronic search with time and language restrictions was conducted. Several known databases were included: PubMed, The Cochrane Library, and Web of Science from 1990 to 2020. We combined the search terms and limited the study to the English language. We removed duplicates, and the articles were screened based on title, abstract, and full text according to the PRISMA checklist.</p> </sec><sec> <title>Results</title> <p>The electronic search strategy conducted in this review resulted in 409 hits. After removing duplicate studies and studies with inadequate information, 20 case studies were finally included in this analysis, 65% of which presented men (n = 13), and seven presented women (35%). The mean age reported in these studies was 54.75 with a standard deviation of 14.62 years. We found that visual disturbances that can lead to visual loss were present in most cases (75% of cases). Other symptoms included headache (35%) and eye pain (30%). The risk factors for developing optic neuropathy conditions related to OC mucoceles include being Asian and elderly with a history of either nasal or eye conditions. Our findings showed that the mean time between the onset of symptoms and intervention was 16.8 ± 21.8 days. Most patients underwent endoscopic sinus surgery to remove the OC mucocele (18/20; 90%) with a success rate of 77%. Pharmacologic intervention as a solo treatment (IV corticosteroids or /and antibiotic) was used in only six patients, with a success rate of only 33%. Computed tomography (CT) and magnetic resonance imaging (MRI) is the most commonly used diagnostic tools, with diagnostic success rates of 40% and 82.3%, respectively.</p> </sec><sec> <title>Conclusion</title> <p>Optic neuropathy conditions related to OC mucoceles are very rare. However, a higher incidence of these conditions was observed in elderly Asian patients with a history of nasal or optic conditions. Visual disturbances are the most common symptoms accompanying any type of eye condition. Endoscopic sinus surgery is considered an effective and safe intervention for these patients, and the period between the onset of symptoms and surgery does not affect the outcomes of the surgery. Furthermore, treatment with corticosteroids and/or antibiotics cannot replace surgery and it can also worsen the condition. Moreover, MRI is superior to CT scans for demonstrating this abnormality, and both are superior to other diagnostic tools. Finally, further investigations should be conducted to study the causes of the low incidence of these conditions in the eastern region.</p> </sec></abstract>

Publisher

American Institute of Mathematical Sciences (AIMS)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Computed tomographic study on the prevalence of the Onodi cell;Nigerian Journal of Basic and Clinical Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3